|
2025
|
Invention
|
Mrgprx2 antagonists, pharmaceutical composition including mrgprx2 antagonist, and method of treat... |
|
|
Invention
|
1h-pyrrolo[2,3-b]pyridine derivatives as mrgprx2 antagonists for the treatment of inflammatory di... |
|
2024
|
Invention
|
Method for producing compound encoded by oligonucleotide, and application thereof. The purpose of... |
|
|
Invention
|
Alternative thinking assistance device, alternative thinking assistance program, and alternative ... |
|
2022
|
Invention
|
Pharmaceutical composition for fibrosis treatment. Provided is a fibrosis treatment agent includi... |
|
|
Invention
|
Agent for treating nocturnal pollakiuria.
[Problem] To provide a novel therapeutic agent for noc... |
|
|
Invention
|
Reaction treatment container and reaction treatment device. This reaction treatment container has... |
|
2021
|
Invention
|
Pharmaceutical composition, method for producing cell, cell, method for producing surfactant prot... |
|
|
Invention
|
Nucleic acid amplification chip.
In a nucleic acid amplification chip, a filter is provided insi... |
|
|
Invention
|
Nucleic acid amplification device, nucleic acid amplification method, and sample solution positio... |
|
|
Invention
|
Nucleic acid amplification chip. This nucleic acid amplification chip includes a filter for micro... |
|
2020
|
Invention
|
G9a inhibitor. It was found that a compound represented by general formula (I) or a pharmaceutica... |
|
|
Invention
|
Respiratory infection treating agent.
[Problem] The present invention pertains to a safer and mo... |
|
|
P/S
|
Pharmaceutical preparations. |
|
|
Invention
|
Urea derivative or pharmacologically acceptable salt thereof. Provided is a compound having a for... |
|
|
Invention
|
Method for producing 4-oxopyrrolidine-3-carboxamide derivatives. [Problem] To provide a novel met... |
|
|
Invention
|
Nucleic acid amplification method. A reciprocal flow-type nucleic acid amplification method which... |
|
|
Invention
|
Aqueous drug.
An aqueous drug in which the chemical decomposition of the compound represented by... |
|
|
Invention
|
Nucleic acid amplification device, nucleic acid amplification method, and chip for nucleic acid a... |
|
|
Invention
|
15-pgdh inhibitors. A compound having one of formula (1), formula (2), formula (3) and formula (4... |
|
|
Invention
|
15-pgdh inhibitor.
[Problem]
[Problem]
To provide a compound having a 15-PGDH inhibitory effec... |
|
|
Invention
|
15-pgdh inhibitor. [Problem] To provide a compound having a 15-PGDH inhibitory effect. [Solution]... |
|
2019
|
Invention
|
Effervescent tablet containing sodium dichloroisocyanurate. [Problem] To provide a sodium-dichlor... |
|
|
Invention
|
Pcr reaction container. A PCR reaction container which comprises: a substrate; a flow channel for... |
|
|
Invention
|
Bicyclic heteroaromatic ring derivative. [Problem] To provide a compound having an antiviral acti... |
|
|
Invention
|
Agent for inhibiting recurrence of hematological malignancy in patients who have undergone hemato... |
|
|
Invention
|
Therapeutic agent for fibrosis.
Disclosed is an antisense nucleic acid that suppresses NEK6 gene... |
|
|
Invention
|
Therapeutic agent for fibrosis. Disclosed is an antisense nucleic acid that suppresses the expres... |
|
2018
|
Invention
|
Agent for treating nocturnal pollakiuria. [Problem] To provide a novel therapeutic agent for noct... |
|
|
Invention
|
Therapeutic agent for nocturnal pollakiuria. [Problem] To provide a novel therapeutic agent for n... |
|
|
Invention
|
Respiratory infection treating agent. [Problem] The present invention pertains to a safer and mor... |
|
|
Invention
|
Therapeutic agent for fibrosis. Disclosed is a phosphorylation inhibitor of SMAD2/3 protein or a ... |
|
|
Invention
|
Therapeutic agent for fibrosis. Disclosed is a phosphorylation inhibitor for SMAD2/3 proteins or ... |
|
|
Invention
|
Therapeutic agent for aspiration pneumonia, lung suppuration, or lung abscess.
[Problem]
[Prob... |
|
|
Invention
|
Therapeutic agent for aspiration pneumonia, lung suppuration, or lung abscess. [Problem] The pres... |
|
|
Invention
|
7-{(3s,4s)-3-[(cyclopropylamino)methyl]-4-fluoropyrrolidine-1-yl}-6-fluoro-1-(2-fluoroethyl)-8-me... |
|
2017
|
Invention
|
Dosage regimen of diaryl sulfide derivatives.
A compound of formula I:
A compound of formula I... |
|
2016
|
Invention
|
Vasopressin-like action enhancer. A problem to be solved by the present invention is to provide a... |
|
|
Invention
|
Aqueous drug. An aqueous drug that contains the compound represented by formula (1) or a salt the... |
|
|
Invention
|
Aqueous drug. An aqueous drug in which the chemical decomposition of the compound represented by ... |
|
|
Invention
|
Aqueous liquid formulation. A novel technique with which it is possible to suppress chemical degr... |
|
|
Invention
|
Urea derivative or pharmacologically acceptable salt thereof. The present invention provides a ur... |
|
1967
|
P/S
|
Medicines and drugs. |
